✦ LIBER ✦

Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis

✍ Scribed by Andersen, O

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methylprednisolone in combination with i

✍ Mads Ravnborg; Per Soelberg Sørensen; Magnus Andersson; Elisabeth G Celius; Pete 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 374 KB

Randomised double-blind placebo-controll

✍ George C Ebers 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 97 KB

Daclizumab in active relapsing multiple

✍ Daniel Wynn; Michael Kaufman; Xavier Montalban; Timothy Vollmer; Jack Simon; Jac 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 456 KB

Clinical trial: a multicentre, randomize

✍ C. PENA-ROSSI; S. SCHREIBER; G. GOLUBOVIC; A. MERTZ-NIELSEN; J. PANES; D. RACHMI 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

Efficacy and safety of oral fumarate in

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Interferon beta-1a for brain tissue loss

✍ Massimo Filippi; Marco Rovaris; Matilde Inglese; Frederik Barkhof; Nicola De Ste 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 181 KB